Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ICCC
#3451
Immucell Corp
6.4
0
+0.79%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.79%
Monthly Change
+0.63%
6 month change
+4.40%
Year Change
+21.67%
Previous Close
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
Volume
3
Markets
US Stock Market
Healthcare
ICCC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio
ImmuCell shifts focus to First Defense after FDA setback for Re-Tain
Top Stock Reports for AbbVie, Coca-Cola & Chevron
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength